DD DuPont de Nemours, Inc.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company has a collaboration with Microsoft and NobleAI to expand access to advanced AI tools and resources, including machine learning that helps scientists and engineers innovate faster. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.…
Industry Peers
Specialty ChemicalsKey Statistics
About DuPont de Nemours (NYSE: DD)
›
DuPont de Nemours (NYSE: DD) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 15,000 employees.
The shares were at 150.73 USD on 20 November 2026, up 27.3% over 52 weeks. Its 52-week range is 111.15 USD to 159.48 USD: the price is 5.5% below the high and 35.6% above the low.
At a market capitalisation of 19.84B USD, it trades at 52.2 times trailing earnings and 18.3 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 32.7, a premium of 59% for DD. It pays a dividend yielding 1.60% (it pays out 84% of its earnings), against a median of 1.91% among the dividend payers in that peer group.
DuPont de Nemours reports return on equity of -5.6%, an operating margin of 14.4% and revenue up 4.1% year over year.
Its debt exceeds its cash by 1.53B USD, a debt-to-equity ratio of 0.23. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 17 analysts cover the stock, with an average rating of Buy; their mean price target of 172.47 USD is 14.4% above the current price. The next earnings report is expected on 9 February 2027.